Automechanika Dubai 2025 opens tomorrow with record participation

Automechanika Dubai 2025 Opens Tomorrow at Dubai World Trade Centre

Dubai, UAE – The global automotive aftermarket community will converge at the Dubai World Trade Centre from 9–11 December 2025 for Automechanika Dubai 2025, the largest and most internationally diverse edition in the event’s 22‑year history.

This year’s exhibition will host over 2,300 exhibitors from more than 60 countries, showcased across 20 halls with 20 international pavilions. Reflecting an 11% increase in floor space year‑on‑year, the show now spans 92,000 sqm, underscoring its position as the Middle East and Africa’s leading trade exhibition for the automotive aftermarket and services industry.

Government backing has strengthened further, with support from the Ministry of Energy and Infrastructure and Dubai’s Roads and Transport Authority (RTA), alongside international associations including AfCFTA, CLEPA, and IRU.

The exhibition floor will highlight 10 product categories, ranging from parts and components to digital solutions and autonomous driving. A comprehensive programme of conferences and workshops will run in parallel, focusing on sustainability, innovation, digitalisation, and electrification.

Key features include the Automechanika Academy, Innovation4Mobility, Afri Connections, and new forums such as CV Evolution, Fleet FWD, and LABX. The Automechanika Dubai Awards return on 10 December, celebrating excellence and innovation across the aftermarket sector.

  • Related Posts

    Keeta Powers Jeddah-Born White Heart’s Delivery Success

    From In-Store Favorite to 450 Daily Orders on Keeta Jeddah, Saudi Arabia – 30april2026 – White Heart, one of Jeddah’s most recognized premium dessert brands, has successfully scaled its delivery…

    Continue reading
    Novo Nordisk Announces Landmark Phase 3 Success for Etavopivat in Sickle Cell Disease Treatment

    BAGSVAERD, DENMARK — Novo Nordisk today announced positive topline results from HIBISCUS, a pivotal Phase 3 trial evaluating etavopivat, a once-daily oral PKR activator for adults and adolescents living with…

    Continue reading